Significant difference in Cmax of Reference drug product [Study As­sess­ment]

posted by Mehul Patel – India, 2021-08-17 12:00 (470 d 08:10 ago) – Posting: # 22520
Views: 1,637

Hi,

Can anybody please tell what may be the probable reasons behind significant (more than 20%) difference in mean Cmax concentration of Reference product of a same batch number in two different studies conducted at same CRO and on the similar kind of population but different sample size?

Is it correct to compare and expect Reference product's behavior same for all repeated studies?

Moreover, Can 6 months old (frozen) samples yield significant different results as compared to freshly analyzed study samples?

Complete thread:

UA Flag
Activity
 Admin contact
22,418 posts in 4,693 threads, 1,598 registered users;
18 visitors (0 registered, 18 guests [including 4 identified bots]).
Forum time: 19:11 CET (Europe/Vienna)

Intellect distinguishes between the possible and the impossible;
reason distinguishes between the sensible and the senseless.
Even the possible can be senseless.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5